Background: Patients with anaplastic thyroid cancer (ATC) have a dismal prognosis, despite
systemic cytotoxic chemotherapy. The objective of this study was to investigate the efficacy …

Objective The treatment of anaplastic thyroid cancer (ATC) has continued to rapidly evolve
over time. Increased utilization of novel, personalized therapies based upon the tumour's …

Aims Anaplastic thyroid cancer (ATC) is a rare but aggressive form of thyroid cancer with a
median survival of 4 months. Recent advances in molecular profiling have shown that up to …

Anaplastic thyroid carcinoma (ATC) is a rare, but devastating disease. Despite multimodal
approaches combining surgery, chemotherapy and radiation therapy, ATC is associated …

Anaplastic thyroid cancer (ATC) is an infrequent thyroid tumor that usually occurs in elderly
patients. There is often a history of previous differentiated thyroid cancer suggesting a …

PURPOSE Anaplastic thyroid cancer (ATC), an aggressive malignancy, is associated with a
poor prognosis and an unmet need for effective treatment, especially for patients without …

Purpose Anaplastic thyroid cancer (ATC) is a rare and highly aggressive cancer for which
effective systemic therapy has long been sought. Here, we assessed the efficacy and safety …

Background Anaplastic thyroid cancer (ATC) has dismal prognosis and there is no effective
treatment. We aimed to evaluate the efficacy of tyrosine kinase inhibitor (TKI) therapy in real …

Simple Summary The exceedingly aggressive and rare tumor, anaplastic thyroid carcinoma,
is generally resistant to traditional antitumor therapies. In recent years, targeted therapy has …

Anaplastic thyroid cancer (ATC) is undoubtedly the thyroid cancer histotype with the poorest
prognosis. The conventional treatment includes surgery, radiotherapy, and conventional …